Skip to content

Study · Not a test of the peptide alone · 2013

3 results

Generation and evaluation of antibodies against human MGF E-peptide by reverse phase protein microarray and reverse competitive ELISA.

Du H, Li C, Jin H, Chen G, Xun Y

Bioanalysis1 Sept 2013Cited by 10 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study3

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone3

In this study, MGF / PEG-MGF was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking MGF / PEG-MGF.

  1. 01LabNot a test of MGF / PEG-MGF aloneIn vitro (cell-free)Activity measurement

    All four polyclonal antibodies against MGF C-terminal peptides identified their corresponding antigen in mouse serum by reverse-phase protein microarray.

    In plain wordsIn lab tests, all four antibodies made against MGF pieces found their matching target in mouse serum.

    Outcome
    Not applicableAntibody recognition of antigen in mouse serum
    Study

    n: not reported in source

    Mouse serum, reverse-phase protein microarray
    Outcome group
    Analytical methods and detection · Pharmacology

    Source sentences

    Summary
    It was found that all the antibodies could identify their corresponding antigen in mouse serum by reverse-phase protein microarray, in particular, Ab-K01 showed the highest affinity among them and might be a potential tool for the detection of antibody affinity.
    1 context sentence
    Summary · context
    Four polyclonal antibodies (Ab-K01, Ab-B01, Ab-B02 and Ab-K02) against MGF C-terminal peptides were generated, purified and evaluated by western blot, ELISA and reverse-phase protein microarray, respectively.

    In this study, MGF / PEG-MGF was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking MGF / PEG-MGF.

  2. 02LabNot a test of MGF / PEG-MGF aloneIn vitro (cell-free)Activity measurement

    Ab-K01 showed the highest affinity of the four antibodies against MGF C-terminal peptides in reverse-phase protein microarray.

    In plain wordsIn lab tests, one of the four antibodies, Ab-K01, bound its MGF target most strongly.

    Outcome
    Not applicableAntibody affinity of Ab-K01
    Study

    n: not reported in source

    Outcome group
    Analytical methods and detection · Pharmacology

    Source sentences

    Summary
    It was found that all the antibodies could identify their corresponding antigen in mouse serum by reverse-phase protein microarray, in particular, Ab-K01 showed the highest affinity among them and might be a potential tool for the detection of antibody affinity.
    1 context sentence
    Summary · context
    Four polyclonal antibodies (Ab-K01, Ab-B01, Ab-B02 and Ab-K02) against MGF C-terminal peptides were generated, purified and evaluated by western blot, ELISA and reverse-phase protein microarray, respectively.

    In this study, MGF / PEG-MGF was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking MGF / PEG-MGF.

  3. 03LabNot a test of MGF / PEG-MGF aloneIn vitro (cell-free)Activity measurement

    Ab-B01 and Ab-K01 were successfully used for the determination of MGF-40 by reverse competitive ELISA.

    In plain wordsIn lab tests, two of the antibodies measured MGF-40 successfully with a competitive ELISA test.

    Outcome
    Not applicableMGF-40 determination by reverse competitive ELISA
    Study

    n: not reported in source

    Outcome group
    Analytical methods and detection · Pharmacology

    Source sentences

    Summary
    Furthermore, Ab-B01 and Ab-K01 were successfully used for the determination of MGF-40 by reverse competitive ELISA.

    In this study, MGF / PEG-MGF was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking MGF / PEG-MGF.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 21:44 UTC

    Study results updated

  2. Version 1

    13 Oct 2026, 16:31 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.